A comparative study of HIV-1 and HTLV-I protease structure and dynamics reveals a conserved residue interaction network

被引:7
|
作者
Ruecker, Pia [1 ,2 ]
Horn, Anselm H. C. [1 ,2 ]
Meiselbach, Heike [1 ,2 ]
Sticht, Heinrich [1 ,2 ]
机构
[1] Univ Erlangen Nurnberg, Inst Biochem, D-91054 Erlangen, Germany
[2] Univ Erlangen Nurnberg, Emil Fischer Zentrum, D-91054 Erlangen, Germany
关键词
Molecular dynamics simulation; Protein structure; Protein-ligand interactions; HIV; HTLV; CELL LEUKEMIA-VIRUS; FREE-ENERGY CALCULATIONS; DRUG-RESISTANT MUTANTS; MOLECULAR-DYNAMICS; FORCE-FIELD; SUBSTRATE-SPECIFICITY; ASPARTIC PROTEASES; CRYSTAL-STRUCTURES; INHIBITOR BINDING; TYPE-1; PROTEASE;
D O I
10.1007/s00894-011-0971-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The two retroviruses human T-lymphotropic virus type I (HTLV-I) and human immunodeficiency virus type 1 (HIV-1) are the causative agents of severe and fatal diseases including adult T-cell leukemia and the acquired immune deficiency syndrome (AIDS). Both viruses code for a protease that is essential for replication and therefore represents a key target for drugs interfering with viral infection. The retroviral proteases from HIV-1 and HTLV-I share 31% sequence identity and high structural similarities. Yet, their substrate specificities and inhibition profiles differ substantially. In this study, we performed all-atom molecular dynamics (MD) simulations for both enzymes in their ligand-free states and in complex with model substrates in order to compare their dynamic behaviors and enhance our understanding of the correlation between sequence, structure, and dynamics in this protein family. We found extensive similarities in both local and overall protein dynamics, as well as in the energetics of their interactions with model substrates. Interestingly, those residues that are important for strong ligand binding are frequently not conserved in sequence, thereby offering an explanation for the differences in binding specificity. Moreover, we identified an interaction network of contacts between conserved residues that interconnects secondary structure elements and serves as a scaffold for the protein fold. This interaction network is conformationally stable over time and may provide an explanation for the highly similar dynamic behavior of the two retroviral proteases, even in the light of their rather low overall sequence identity.
引用
收藏
页码:2693 / 2705
页数:13
相关论文
共 50 条
  • [41] COMPARISONS OF CONFIRMED AND UNCONFIRMED HIV-1 AND HTLV-I POSITIVE DONORS TO THE DONOR BASE
    HALEY, NR
    WILLIAMSON, PB
    HOPKINS, CH
    SQUIRES, JE
    TRANSFUSION, 1992, 32 (08) : S30 - S30
  • [42] HIV-1, HIV-2 AND HTLV-I INFECTION IN HIGH-RISK GROUPS IN SPAIN
    SORIANO, V
    TOR, J
    RIBERA, A
    CLOTET, B
    MUGA, R
    PAUPLANA, M
    FERNANDEZ, JL
    MARTIN, J
    FOZ, M
    AIDS, 1989, 3 (09) : 615 - 616
  • [43] HTLV-I, HIV-1 AND HIV-2 SEROPREVALENCES IN GUADELOUPE, FRENCH-WEST-INDIES
    AGIUS, G
    VAILLANT, V
    DINDINAUD, G
    BAZILLOU, M
    ZAGURY, JF
    KOLESNITCHENKO, V
    CASTETS, M
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1989, 5 (04) : 532 - 533
  • [44] HIV-1 and HTLV-I/II dual infections at a New Orleans HIV outpatient clinic.
    Bessinger, R
    Tabak, F
    Kissinger, P
    Jarrott, C
    Beilke, M
    JOURNAL OF INVESTIGATIVE MEDICINE, 1996, 44 (01) : A41 - A41
  • [45] Crystal structure of lysine sulphonamide inhibitor reveals the displacement of the conserved flap water molecule in HIV-1 protease
    Wain, M. N. L.
    Bandaranayake, R.
    Peeters, A.
    Jonckers, T. H. M.
    Dierynck, I.
    Schiffer, C. A.
    ANTIVIRAL THERAPY, 2007, 12 (05) : S139 - S139
  • [46] Crystal structure of lysine sulphonamide inhibitor reveals the displacement of the conserved flap water molecule in HIV-1 protease
    Nalam, M. N. L.
    Bandaranayake, R.
    Peeters, A.
    Jonckers, T. H. M.
    Dierynck, I.
    Schiffer, C. A.
    ANTIVIRAL THERAPY, 2007, 12 : S139 - S139
  • [47] THE REX TRANSACTIVATOR OF HTLV-1 BINDS DIRECTLY TO THE HTLV-I REX AND HIV-1 REV RNA RESPONSE ELEMENTS
    BOGERD, HP
    HUCKABY, GL
    AHMED, YF
    GREENE, WC
    CLINICAL RESEARCH, 1991, 39 (02): : A283 - A283
  • [48] RETROVIRUSES (HIV-1/HIV-2, HTLV-I/HTLV-II) DURING 2000-2009: RESIDUAL RISKS
    Pecec, M.
    Necula, N.
    VOX SANGUINIS, 2010, 99 : 304 - 304
  • [49] Development of a multiplex PCR assay for the simultaneous detection and discrimination of HIV-1, HIV-2, HTLV-I and HTLV-II
    Heredia, A
    Soriano, V
    Weiss, SH
    Bravo, R
    Vallejo, A
    Denny, TN
    Epstein, JS
    Hewlett, IK
    CLINICAL AND DIAGNOSTIC VIROLOGY, 1996, 7 (02): : 85 - 92
  • [50] THE HTLV-II REX PROTEIN TRANSREGULATES HTLV-II, HTLV-I AND HIV-1 STRUCTURAL GENE-EXPRESSION
    KIM, JH
    KAUFMAN, PA
    HANLY, SM
    AHMED, YF
    RIMSKY, LT
    GREENE, WC
    CLINICAL RESEARCH, 1990, 38 (02): : A278 - A278